You are here: Industry Insights > Smallpox

News List

FDA Approves Drug to Treat Smallpox americanpharmaceuticalreview
June 09, 2021
The U.S. FDA approved Tembexa (brincidofovir) to treat smallpox. Although the World Health Organization declared smallpox, a contagious and sometimes fatal infectious disease, eradicated in 1980, there have been longstanding concerns that the virus ...
FDA Approves Tembexa (brincidofovir) for the Treatment of Smallpox drugs
June 07, 2021
Chimerix today announced that the U.S. Food and Drug Administration (FDA) has granted Tembexa (brincidofovir) tablets and oral suspension approval for the treatment of smallpox. Tembexa is approved for adult and pediatric patients, including neonates.
How is a vaccine engineered? expresspharma
January 26, 2021
Vaccines are among the most effective means of preventing infectious diseases. Vaccines train our immune system to mount a defence against pathogens by creating antibodies.
HIV+ Patients Lose Immunity to Smallpox Despite Vaccination drugs
January 19, 2020
HIV-infected patients lose immunity to smallpox despite childhood vaccination and immune reconstitution with antiretroviral therapy, according to a study published online December in The Journal of Infectious Diseases.
FDA approves vaccine for smallpox and monkeypox europeanpharmaceuticalreview
September 26, 2019
The US Food and Drug Administration (FDA) has announced the approval of Jynneos, a smallpox and monkeypox vaccine for patients 18 years of age or older at high risk of the condition.
FDA Approves Jynneos (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults drugs
September 25, 2019
Bavarian Nordic A/S announced that the U.S. Food and Drug Administration (FDA) has approved Jynneos™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) (MVA-BN®, liquid-frozen) for prevention ...
FDA approves the first drug with an indication for treatment of smallpox europeanpharmaceuticalreview
July 19, 2018
The US Food and Drug Administration has approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox…
FDA approves first smallpox therapy pharmatimes
July 17, 2018
US regulators have approved the first treatment designed to mitigate the impact of a potential outbreak of smallpox caused by bioterrorism.